{"id":"W2039223287","doi":"10.1177/00912700122012751","title":"Pharmacokinetics of Gemtuzumab Ozogamicin, an Antibody‐Targeted Chemotherapy Agent for the Treatment of Patients with Acute Myeloid Leukemia in First Relapse","year":2001,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":156,"is_retracted":false,"has_abstract":true,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Gemtuzumab ozogamicin; Calicheamicin; Pharmacokinetics; CD33; Medicine; Pharmacology; Myeloid leukemia; Radioimmunotherapy; Chemotherapy; Antibody; Internal medicine; Monoclonal antibody; Immunology; Stem cell; CD34","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001134744,0.0001938168,0.0008828642,0.0001205709,0.00007397291,0.000003115352,0.0003624767,0.0001049316,0.0003177625],"category_scores_gemma":[0.00006056163,0.00008640705,0.0003093696,0.0002299265,0.0005053317,0.00005790666,0.00002989677,0.0004373989,0.000001941729],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001408529,"about_ca_system_score_gemma":0.0003953433,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008164041,"about_ca_topic_score_gemma":0.00002450844,"domain_scores_codex":[0.9973991,0.0003202307,0.001385219,0.0001478854,0.0004291041,0.0003184465],"domain_scores_gemma":[0.9961575,0.002119146,0.0008426863,0.0002045989,0.0005145072,0.000161541],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.3590023,0.01315377,0.4760233,0.0002478098,0.007621204,0.0003705044,0.002507439,0.003296748,0.05002628,0.0000222405,0.01110134,0.07662714],"study_design_scores_gemma":[0.05552317,0.03968332,0.7638049,0.0001100869,0.002360972,0.000158648,0.000138434,0.005319877,0.0200431,0.00007593126,0.1125864,0.0001950782],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9929996,0.0008609563,0.000116,0.004501041,0.0005173429,0.0009042794,0.00004179218,0.000003650652,0.00005540146],"genre_scores_gemma":[0.9488037,0.04862173,0.0003340623,0.001231031,0.0006432848,0.000007650415,0.00001842285,0.00002451732,0.000315591],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3034791,"threshold_uncertainty_score":0.3523577,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05835483957096098,"score_gpt":0.439846833137735,"score_spread":0.381491993566774,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}